147 related articles for article (PubMed ID: 3926458)
1. The mechanism of action of cysteamine in depleting prolactin immunoreactivity.
Sagar SM; Millard WJ; Martin JB; Murchison SC
Endocrinology; 1985 Aug; 117(2):591-600. PubMed ID: 3926458
[TBL] [Abstract][Full Text] [Related]
2. Cysteamine induces depletion of both immunological and biological prolactin activity in the anterior pituitary and blood of the rat.
Millard WJ; Sagar SM; Simpkins JW; Owens RE; Badger TM; Friesen HG; Martin JB
Endocrinology; 1983 Dec; 113(6):2161-7. PubMed ID: 6641630
[TBL] [Abstract][Full Text] [Related]
3. Thiol regulation of depletion-transformation and release of prolactin by the pituitary of the lactating rat.
Mena F; Clapp C; Aguayo D; Lorenson MY; Martinez-Escalera G
Endocrinology; 1986 May; 118(5):1795-802. PubMed ID: 3698895
[TBL] [Abstract][Full Text] [Related]
4. Effects of cysteamine on pituitary, MTTW15 tumor, and serum prolactin levels measured by rat lymphoma cell bioassay and radioimmunoassay.
Parsons JA; Peterson EK; Hartfel MA
Endocrinology; 1984 May; 114(5):1812-7. PubMed ID: 6714167
[TBL] [Abstract][Full Text] [Related]
5. Cysteamine-induced depletion of somatostatin and prolactin.
Millard WJ; Sagar SM; Martin JB
Fed Proc; 1985 Jun; 44(9):2546-50. PubMed ID: 2860016
[TBL] [Abstract][Full Text] [Related]
6. Reversal by thiols of dopamine-, stalk-median eminence-, and zinc-induced inhibition of prolactin transformation in adenohypophyses of lactating rats.
Martinez-Escalera G; Clapp C; Morales MT; Lorenson MY; Mena F
Endocrinology; 1986 May; 118(5):1803-7. PubMed ID: 3698896
[TBL] [Abstract][Full Text] [Related]
7. Cysteamine depletes prolactin (PRL) but does not alter the structure of PRL-containing granules in the anterior pituitary.
Weinstein LA; Landis DM; Sagar SM; Millard WJ; Martin JB
Endocrinology; 1984 Oct; 115(4):1543-50. PubMed ID: 6479101
[TBL] [Abstract][Full Text] [Related]
8. Depletion of bovine pituitary prolactin by cysteamine involves a thiol:disulfide mechanism.
Lorenson MY; Jacobs LS
Endocrinology; 1984 Oct; 115(4):1492-5. PubMed ID: 6479100
[TBL] [Abstract][Full Text] [Related]
9. The 22K variant of rat prolactin: evidence for identity to prolactin-(1-173), storage in secretory granules, and regulated release.
Anthony PK; Stoltz RA; Pucci ML; Powers CA
Endocrinology; 1993 Feb; 132(2):806-14. PubMed ID: 8425495
[TBL] [Abstract][Full Text] [Related]
10. Cysteamine causes reduction of prolactin monomers followed by aggregation in the rat pituitary gland.
Scammell JG; Burrage TG; Eisenfeld AJ; Dannies PS
Endocrinology; 1985 Jun; 116(6):2347-54. PubMed ID: 3996317
[TBL] [Abstract][Full Text] [Related]
11. Changes in molecular variants during in vitro transformation and release of prolactin by the pituitary gland of the lactating rat.
Mena F; Hummelt G; Aguayo D; Clapp C; MartÃnez de la Escalera G; Morales MT
Endocrinology; 1992 Jun; 130(6):3365-77. PubMed ID: 1597148
[TBL] [Abstract][Full Text] [Related]
12. Cysteamine inhibition of bovine pituitary secretory granule prolactin immunoassayability and release.
Lorenson MY
Endocrinology; 1984 Aug; 115(2):728-35. PubMed ID: 6745176
[TBL] [Abstract][Full Text] [Related]
13. Characterization of cysteamine induction of the 22K prolactin variant in the rat pituitary.
Anthony PK; Powers CA
Neuroendocrinology; 1993 Jan; 57(1):167-76. PubMed ID: 8479612
[TBL] [Abstract][Full Text] [Related]
14. Cysteamine acts immediately to inhibit prolactin release and induce cellular changes in estradiol-primed male rats.
Saunders SL; Shin SH; Reifel CW
Neuroendocrinology; 1984 Mar; 38(3):182-8. PubMed ID: 6325979
[TBL] [Abstract][Full Text] [Related]
15. Cysteamine, zinc, and thiols modify detectability of rat pituitary prolactin: a comparison with effects on bovine prolactin suggests differences in hormone storage.
Jacobs LS; Lorenson MY
Metabolism; 1986 Mar; 35(3):209-15. PubMed ID: 3081777
[TBL] [Abstract][Full Text] [Related]
16. In vitro conditions modify immunoassayability of bovine pituitary prolactin and growth hormone: insights into their secretory granule storage forms.
Lorenson MY
Endocrinology; 1985 Apr; 116(4):1399-407. PubMed ID: 3918853
[TBL] [Abstract][Full Text] [Related]
17. Differential isoform distribution between stored and secreted prolactin.
Oetting WS; Walker AM
Endocrinology; 1986 Sep; 119(3):1377-81. PubMed ID: 3732172
[TBL] [Abstract][Full Text] [Related]
18. Quantification of vasoactive intestinal peptide immunoreactivity in the anterior pituitary glands of intact male and female, ovariectomized, and estradiol benzoate-treated rats.
Carrillo AJ; Phelps CJ
Endocrinology; 1992 Aug; 131(2):964-9. PubMed ID: 1639033
[TBL] [Abstract][Full Text] [Related]
19. Cysteamine inhibition of prolactin immunoassayability and secretion: studies with aminothiophenols and other analogs.
Jacobs LS; Lorenson MY
Endocrinology; 1984 Sep; 115(3):1210-7. PubMed ID: 6430683
[TBL] [Abstract][Full Text] [Related]
20. Depletion of pituitary prolactin by cysteamine is due to loss of immunological activity.
Scammell JG; Dannies PS
Endocrinology; 1984 Mar; 114(3):712-6. PubMed ID: 6697959
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
